STOCKWATCH
·
Medical Specialities
Quarterly ResultMay 7, 2026, 05:08 PM

Concentra Q1 Revenue $569.6M, Net Income $50.5M, EPS $0.39

AI Summary

Concentra Group Holdings Parent, Inc. reported strong financial results for the first quarter of 2026, with significant year-over-year increases in revenue, net income, and earnings per share. The company's Segment Adjusted EBITDA also saw substantial growth. During the quarter, Concentra repurchased $15.0 million of its common stock and paid a cash dividend of $0.0625 per share.

Key Highlights

  • Q1 2026 revenue increased to $569.6 million from $500.8 million in Q1 2025.
  • Net income attributable to the Company rose to $50.5 million from $38.9 million year-over-year.
  • Basic and diluted EPS increased to $0.39 in Q1 2026 from $0.30 in Q1 2025.
  • Segment Adjusted EBITDA grew to $120.7 million in Q1 2026 from $102.7 million in Q1 2025.
  • Occupational health center revenue was $519.9 million, with workers' compensation at $337.7 million.
  • Onsite health clinics revenue significantly increased to $37.2 million from $16.6 million.
  • Repurchased 0.7 million common shares for $15.0 million under the $100 million program.
  • Declared and paid a cash dividend of $0.0625 per share, totaling $8.0 million.
CON
Medical Specialities
Concentra Group Holdings Parent, Inc.

Price Impact